Education
About Us
Working with TipRanks
Follow Us
HTG Molecular Diagnostics (HTGMQ)
OTHER OTC:HTGMQ
| Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 6.37M | $ 8.91M | $ 8.55M | $ 19.20M | $ 21.50M |
| Gross Profit | $ 1.79M | $ 4.81M | $ 4.56M | $ 10.29M | $ 16.41M |
| Operating Income | $ -20.83M | $ -17.82M | $ -19.59M | $ -18.96M | $ -16.16M |
| EBITDA | $ -20.14M | $ -15.36M | $ -18.48M | $ -17.08M | $ -15.10M |
| Net Income | $ -21.59M | $ -17.15M | $ -20.87M | $ -19.30M | $ -16.45M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 12.21M | $ 21.94M | $ 28.70M | $ 33.03M | $ 31.11M |
| Total Assets | $ 17.78M | $ 30.46M | $ 35.20M | $ 45.12M | $ 43.77M |
| Total Debt | $ 8.35M | $ 11.71M | $ 12.64M | $ 11.25M | $ 9.68M |
| Net Debt | $ -3.86M | $ 2.11M | $ -9.75M | $ 3.63M | $ 1.25M |
| Total Liabilities | $ 12.39M | $ 20.06M | $ 20.71M | $ 21.15M | $ 22.68M |
| Stockholders' Equity | $ 5.39M | $ 10.40M | $ 14.48M | $ 23.97M | $ 21.09M |
| Cash Flow | |||||
| Free Cash Flow | $ -18.43M | $ -17.15M | $ -16.75M | $ -17.80M | $ -14.12M |
| Operating Cash Flow | $ -18.41M | $ -16.51M | $ -16.29M | $ -16.70M | $ -13.17M |
| Investing Cash Flow | $ 12.42M | $ -6.66M | $ 18.73M | $ -3.50M | $ -23.22M |
| Financing Cash Flow | $ 8.60M | $ 10.39M | $ 9.05M | $ 19.39M | $ 38.13M |
HTG Molecular Diagnostics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.